KalVista Pharmaceuticals, Inc. ( KALV) - Stock Earnings
KALV Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q1 | -52.2 million USD | — USD |
| 2025Q2 | -60.1 million USD | 1.4 million USD |
| 2025Q3 | -5.4 million USD | 59.9 million USD |
| 2026Q2 Est. | — | — |
KALV Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -92.9 million USD | — USD |
| 2024 | -126.6 million USD | — USD |
| 2025 | -183.4 million USD | — USD |
| 2026 Est. | — | — |
KALV
Price: $27
52 week price:
Earnings Per Share: -3.94 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 731100
Ebitda: -22.6 millionMarket Capitalization: 1.4 billion